Fit-for-Fertility Multicenter Randomized Controlled Trial
Obesity | Infertility, FemaleInfertility affects approximately 10-15% of couples and one of its important modifiable risk factor is obesity, which affects 19% of Canadian women of reproductive age. Accordingly, many organizations have recommended that women should be assisted to adopt a healthy lifestyle prior to conception and maintain it during pregnancy. We therefore propose to conduct a multicenter randomized controlled trial (RCT) assessing the lifestyle intervention Fit-For-Fertility in women with infertility and obesity. Our hypothesis is that the Fit-For-Fertility program is an efficient and low cost solution to improve access to motherhood for women suffering from obesity and infertility.
To test our hypothesis, seven fertility clinics having a good ethnic diversity will participate in this RCT and recruit a total of 616 women with obesity (BMI according to ethnicity) who consult at the fertility clinic. Participants will be randomly allocated to one of these two groups: the intervention group will be invited to participate in the Fit-for Fertility Program alone for 6 months and then in combination with usual fertility treatments; while the control group will receive standard fertility treatments from randomisation. The aim of the Fit-for Fertility Program will be to implement progressive and sustainable lifestyle changes, using 1) individual sessions with a dietitian and a kinesiologist every 6-12 weeks, for a total of 18 months or until the end of pregnancy; and 2) eight educational group sessions. Evaluation visits will take place prior to randomisation and then every 6 months for 18 months. Women who become pregnant will be evaluated early during pregnancy and at 26 weeks of gestation. Clinical outcomes will be assessed after a total follow up of 24 months.
Anticipated contributions: The results of our multicenter RCT will provide important data on the importance of a lifestyle program supporting women with obesity consulting in fertility clinics, in order to improve their fertility and response to ART, as well as helping them to have a healthy baby. This study will also provide valuable information on potential cost savings for individuals and the healthcare system.
null
Participation Requirements
-
Sex:
FEMALE -
Eligible Ages:
18 to 40
Participation Criteria
Inclusion Criteria:
1. Infertility defined as (a) failure to achieve a clinical pregnancy after ≥12 months of regular unprotected sexual intercourse, (b) not conceiving after having tried ≥6 months in women with irregular menstrual cycles or ≥35 years of age; or (c) women with an established cause of infertility;
2. Aged between 18 and 40 years; and
3. Obesity (BMI ≥ 30 kg/m² or 27 kg/m² for Asian and Latin American), or overweight for women with PCOS (BMI ≥ 27 kg/m²).
Exclusion Criteria:
1. Any uncontrolled medical or mental condition that contra-indicates fertility treatments, based on clinical judgment of the fertility specialist;
2. If the only clinically indicated MAR procedure is IVF (e.g. bilateral tubal factor, severe male factor, etc.) or in case of insemination with donor, because natural conception is impossible or highly unlikely;
3. Recurrent spontaneous abortions (\>2 miscarriages at less than 22 weeks of gestation) within the last 12 months (with evidence of conception, such as positive β-hCG), because these women do not have difficulty to conceive.
4. Previously diagnosed uncontrolled eating disorder or major depression that would contra-indicate the initiation of a lifestyle intervention;
5. A high level of depressive state, as determined by a score for depression on the Hospital Anxiety and Depression Scale (HADS) ≥ 15, since that would contra-indicate the initiation of a lifestyle intervention;
6. Planning for or past history of bariatric surgery;
7. Planning for or engaging in another intensive lifestyle intervention (that includes face-to-face visits every 8 weeks or less, which would be similar to the intervention tested);
8. Inability to understand the language in which group sessions will be provided in the participating center, i.e. French in Quebec province and English in other provinces; and
9. Planning to be unable to attend research visits at the participating center for the next 18 months, due to moving in another region, for example.
Study Location
IWK Health Centre
IWK Health CentreHalifax, New Brunzwick
Canada
Contact Study Team
Centre hospitalier universitaire de Sherbrooke
Centre hospitalier universitaire de SherbrookeSherbrooke, Quebec
Canada
Contact Study Team
Marie-Hélène Pesant, MD
Frances Gallagher, PhD
Belina Carranza-Mamane, MD
William Fraser, MD
Marie-France Langlois, MD
Thomas Poder, PhD
Jean-Patrice Baillargeon, MD
Olive Fertility Centre
Olive Fertility CentreVancouver, British Columbia
Canada
Contact Study Team
Elizabeth Taylor, MD
Centre hospitalier de l'Université Laval
Centre hospitalier de l'Université LavalQuébec, Quebec
Canada
Contact Study Team
Anne-Sophie Morisset, PhD
Weilin Kong, MD
Mount Sinai Hospital
Mount Sinai HospitalToronto, Ontario
Canada
Contact Study Team
Pacific Centre for Reproductive Medicine
Pacific Centre for Reproductive MedicineEdmonton, Alberta
Canada
Contact Study Team
Centre hospitalier de l'Université de Montréal (CHUM)
Centre hospitalier de l'Université de Montréal (CHUM)Montréal, Quebec
Canada
Contact Study Team
Carole N. Kamga-Ngandé, MD
Ariane Godbout, MD
- Study Sponsored By
- Université de Sherbrooke
- Participants Required
- More Information
- Study ID:
NCT03908099